Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity
- PMID: 8609615
- DOI: 10.1006/jmbi.1996.0069
Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity
Abstract
The present study set out to investigate whether phage display could be used to improve the properties of a high-affinity human monoclonal antibody directed against the third hypervariable loop (V3 loop) of human immunodeficiency virus (HIV). The aim was to increase affinity through slowing the dissociation rate (off-rate constant of koff), whilst retaining the ability of this antibody to bind diverse V3 loop sequences. When reformatted as a scFv, the antibody fragment retained the properties of the parental IgG, including the ability to neutralise virus. Heavy and light chains were sequentially replaced with repertoires of variable domains from non-immunised human donors followed by selection on biotinylated synthetic peptide. All selected variants derived from the same germline as the parental antibody. Variants of the light chain provided little if any improvement, whereas two residue changes in VHCDR2 and one in VHFR3 resulted in a reduced koff from gp120 protein of the MN strain (MNgp120) and synthetic V3 loop peptides as measured by surface plasmon resonance using the BIAcore instrument (Pharmacia Biosensor). VHCDR3 was modified using synthetic oligonucleotides and several clones with reduced koff identified, a number of different substitutions occurring at a single residue position. The residues in the heavy chain identified as reducing koff were simultaneously randomised by site-directed mutagenesis, resulting in scFv variants with koff slowed up to sevenfold. Far from compromising recognition of variant loops, binding to these sequences was improved; the koff from synthetic peptides modelled on V3 loop variants being slowed to a degree similar to that observed with MNgp120. All four changes were located towards either extremes of CDRs 2 and 3, suggesting that the mechanism of improvement may be one of alternation of loop conformation. This work illustrates that phage display can be used to tailor the properties of a therapeutic monoclonal antibody in a predefined fashion.
Similar articles
-
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588. Biochem J. 2006. PMID: 16827663 Free PMC article.
-
Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.J Virol. 2007 Apr;81(8):3757-68. doi: 10.1128/JVI.01544-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251298 Free PMC article.
-
Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.Eur J Immunol. 1996 Jul;26(7):1634-40. doi: 10.1002/eji.1830260734. Eur J Immunol. 1996. PMID: 8766572
-
Structural studies of human HIV-1 V3 antibodies.Hum Antibodies. 2005;14(3-4):73-80. Hum Antibodies. 2005. PMID: 16720977 Review.
-
Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S47-52. AIDS Res Hum Retroviruses. 1994. PMID: 7865333 Review.
Cited by
-
Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Antimicrob Agents Chemother. 2012 Sep;56(9):4569-82. doi: 10.1128/AAC.00567-12. Epub 2012 Jun 4. Antimicrob Agents Chemother. 2012. PMID: 22664969 Free PMC article. Review.
-
The role of phage display in therapeutic antibody discovery.Int Immunol. 2014 Dec;26(12):649-57. doi: 10.1093/intimm/dxu082. Epub 2014 Aug 18. Int Immunol. 2014. PMID: 25135889 Free PMC article. Review.
-
Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo.Br J Pharmacol. 2011 Jan;162(2):480-90. doi: 10.1111/j.1476-5381.2010.01061.x. Br J Pharmacol. 2011. PMID: 20942844 Free PMC article.
-
Combinatorial peptidomics: a generic approach for protein expression profiling.J Nanobiotechnology. 2003 Jul 3;1(1):4. doi: 10.1186/1477-3155-1-4. J Nanobiotechnology. 2003. PMID: 12877747 Free PMC article.
-
Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.MAbs. 2018 Jan;10(1):104-117. doi: 10.1080/19420862.2017.1384892. Epub 2017 Oct 24. MAbs. 2018. PMID: 28952876 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources